Leaderboard

En | De
Sie sind hier: Onkologie » Urologische Tumoren 18. November 2026
Suchen
medline.ch
Urologische Tumoren
Erweiterte Suche
Dermatologie
Endokrinologie
Ernährung
Gastroenterologie
Gynäkologie
Hämatologie
Infektiologie
Kardiovaskuläre Erkrankungen
Muskuloskelettale Erkrankungen
Neurologie
Onkologie
Bewegungsapparat
Blut
Endokrine Organe
Gynäkologische Tumoren
Haut
Magen-Darm
ORL
Respirationstrakt
Urologische Tumoren
ZNS
Ophthalmologie
ORL
Pädiatrie
Psychiatrie
Respirationstrakt
Sportmedizin
Urologie-Nephrologie
Schrift: Schrift grösser Schrift kleiner

Rect Top
   Seite 1 von 9153  vorhergehende Seite nächste Seite
   
   Artikel 1 - 20 / 183051  
   
Effects of cabozantinib monotherapy starting dose on treatment outcomes in metastatic renal cell carcinoma: A real-world cohort study from Southwest Finland.
Ther Adv Urol
Kosola S, Ahtiainen L, Miedema J, Mårdby AC, Rockberg J, Perrot V, Kauko T, Tapana L, Mattila KE.
PMID: 43048443 [PubMed]


Exosomal and extracellular-vesicle miRNAs in prostate cancer-bone communication: mechanisms, biomarkers, and translational challenges.
Front Cell Dev Biol
Shen Y, Ju B.
PMID: 43048074 [PubMed]


PD-1/PD-L1 inhibitor-based regimens in sarcomatoid renal cell carcinoma: a meta-analysis of randomized controlled trials and single-arm studies.
Front Immunol
Zheng K, Zhang L, Huang Z, Ye B, Ren P, Zhang Q.
PMID: 43047712 [PubMed - in process]


Hydrogel-Based Therapies for Bladder Cancer: Intravesical Delivery, Immunomodulation, and Precision.
Tissue Eng Part B Rev
Han J, Li X, Zhou X, Zhang Y.
PMID: 43046810 [PubMed - as supplied by publisher]


A Self-Confined Rotational Hydrogel Chemiluminescence Motor Array for Rapid and Sensitive Detection of Bladder Cancer Biomarkers.
Anal Chem
Wang W, Xing Z, Wang B, Zheng S, Zeng L, Wang J.
PMID: 43046401 [PubMed - in process]


Prediagnostic circulating 25-hydroxyvitamin D and prostate cancer-specific survival: a collaborative pooled analysis of 13 prospective studies.
BMC Med
Huang J, Perez-Cornago A, Travis RC, Appleby PN, Chen D, Parsaeian M, Noor U, Weinstein SJ, Freedman ND, Josefsson A, Johansson I, Platz EA, Joshu CE, Yeap BB, Flicker L, Mucci LA, Tsilidis KK, Knekt P, Lutsey PL, Mondul A, Visvanathan K, Helzlsouer KJ, Giles GG, Schulze MB, Deschasaux-Tanguy M, Touvier M, Huerta JMª, Le Marchand L, Stampfer M, Key TJ, Albanes D, Allen NE.
PMID: 43046181 [PubMed - in process]


Diagnostic utility of plasma and urine KIM-1 levels in clear cell renal cell carcinoma: an observational prospective study.
BMC Urol
Ratajczyk K, Marek-Bukowiec K, Karwacki J, Kowal P, Pietrus M, Fiutowski M, Witkiewicz W, Kisia, Szyde, Ma, Ko.
PMID: 43046032 [PubMed - in process]


Association of metformin use with metabolic trajectories and disease progression in prostate cancer patients receiving androgen deprivation therapy: a target trial emulation study.
BMC Urol
He Y, Tang L, Yuan K, Liu H, Huang Z, Liu Z, Liu Y, Yang Q, Chen B.
PMID: 43046007 [PubMed - in process]


A Conventional T1WI-Derived Signal Ratio for Differentiating Granulomatous Prostatitis From Prostate Cancer: A Two-Center Study.
Acad Radiol
Zhao L, Wang L, Yang X, Liang G, Yan X, Liu R, Yan J.
PMID: 43045591 [PubMed - as supplied by publisher]


Active surveillance for low-risk prostate cancer: protocol for a systematic review and meta-analysis of observational cohort studies.
BMJ Open
de Lima JB, Mann MB, Leitão SAT, Baptista TM, Bessel M, Basso J, Zordan RA, Isaacsson P.
PMID: 43045147 [PubMed - in process]


Mass spectrometry and machine learning for classification and molecular phenotyping of renal cell carcinoma and benign tumors.
Mol Cell Proteomics
Sparre AA, Rabjerg M, Marcussen N, Lund L, Jensen ON.
PMID: 43045040 [PubMed - as supplied by publisher]


Alcohol use reduces the efficacy of anti-PD1 immunotherapy by disrupting antitumor immunity.
Sci Signal
Gilley KN, Garness J, Khan A, Materia BR, Carpenter B, Shabrang M, Beckabir W, Woodcock MG, Pecot CV, Vincent BG, Coleman LG Jr.
PMID: 43043991 [PubMed - indexed for MEDLINE]


The 32nd Annual Prostate Cancer Foundation Scientific Retreat Report.
Prostate
Miyahira AK, Koo PJ.
PMID: 43043976 [PubMed - as supplied by publisher]


Functional recovery after robot-assisted radical prostatectomy: a patient-centred perspective.
J Robot Surg
Mastroianni R, Ragusa A, Iannuzzi A, Leccese F, Anceschi U, Bove AM, Brassetti A, D'Annunzio S, Ferriero M, Flammia RS, Guaglianone S, Spadaro G, Nardi M, Bologna E, Chiacchio G, Licari LC, Proietti F, Tuderti G, Leonardo C, Papalia R, Simone G.
PMID: 43043519 [PubMed - indexed for MEDLINE]


Robot-assisted partial nephrectomy with venous tumor thrombectomy for classic renal angiomyolipoma: standardized technique and short-term outcomes.
World J Urol
Jia Z, Chen Y, Yang Z, Liu K, Song J, Jiao Q, Peng C, Zhao C, Peng X, Li S, Ding X, Li Q, Wang H, Gong M, Xu Y, Xu J, Pahernik S, Zhang X, Ma X, Huang Q.
PMID: 43043499 [PubMed - indexed for MEDLINE]


Opioid-free anaesthesia versus opioid-based anaesthesia for laparoscopic radical prostatectomy: a prespecified analysis of a single-centre randomized controlled trial.
World J Urol
Maciejewski P, Cicio M, Kwinta A, Maciejewska K, , Szpunar W, Klimczyk T, Szpor J, Bugielska R, Lonc T, Drygalski T, Sk.
PMID: 43043486 [PubMed - indexed for MEDLINE]


Regional disparities in clinicopathological characteristics and overall survival after radical nephroureterectomy for upper tract urothelial carcinoma: a multi-institutional cohort study across European and Taiwanese centers.
World J Urol
Miszczyk M, Yu CC, Roessler N, Gontero P, Soria F, Tomasik B, Pradere B, Ferro M, N'Dow J, Shariat SF, D'Andrea D, Tsai YC, PARALLAX-EAU working group.
PMID: 43043482 [PubMed - indexed for MEDLINE]


Kidney-sparing management of bilateral synchronous upper tract urothelial carcinoma: redefining what was once inevitable.
World J Urol
Scilipoti P, Zorzi F, Nannola N, Gonzalez CG, Folcia A, Robesti D, Occhi A, Ventimiglia E, Montorsi F, Briganti A, Salonia A, Moschini M, Doizi S, Panthier F, Villa L, Traxer O.
PMID: 43043481 [PubMed - indexed for MEDLINE]


Spatial Immune Organization Associates with Response to CD40 Agonism in BCG-Unresponsive Non-Muscle-Invasive Bladder Cancer: A Phase I Trial.
Clin Cancer Res
Osorio JC, Blanchard L, Yao N, Alam SM, Ghasemzadeh A, Grudman S, Whiting K, Seshan VE, Mijacika A, Sevilla C, Angulo-Lozano JC, Sharma VP, Tomberlin M, McCarter M, Pfau J, Wong JL, Knorr DA, Donahue TF, Smith R, Pietzak EJ, Greenbaum B, Al-Ahmadie H, Rosenberg JE, Ravetch JV, Bochner B.
PMID: 43043010 [PubMed - as supplied by publisher]


Mimickers of Prostate Cancer: From Adenosis to Xanthoma.
Arch Pathol Lab Med
Kryvenko ON, Epstein JI.
PMID: 43042953 [PubMed - as supplied by publisher]


   
   Artikel 1 - 20 / 183051    Seite 1 von 9153  vorhergehende Seite nächste Seite

 
Rect Bottom
Adserver Footer
 

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

 

Übersetzungsproblem?

mehr >>

  Zeitfenster  
   

Sky right 1